Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

The Relationship Between Cold Chain Logistics and Cell & Gene Therapies

April 29, 2024

A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more.

Berry Global Increases Manufacturing Capacity

April 29, 2024

The CDMO’s boost in production will be centered around pharmaceutical products.

Pharma Pulse 4/29/24: Going Beyond Visuals to Connect with Diverse Audiences, Invensify Introduces Energy Efficient Cold Chain Shipping Transporter & more

April 29, 2024

The latest news for pharma industry insiders.

Examining Drug Shortages Before and During the COVID-19 Pandemic

April 26, 2024

There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?

Walgreens Debuts Specialty Pharma Business

April 26, 2024

The move features the launch of an innovation center revolving around cell and gene services.

Pharma Pulse 4/26/24: Amazon Introduces Custom AI Capabilities, Crafting Culturally Sensitive Messages to Reach Diverse Audience & more

April 26, 2024

The latest news for pharma industry insiders.

Kühne Holding Inks Deal for Aenova

April 25, 2024

The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.

Eli Lilly Purchases Nexus Pharmaceutical Injectables Manufacturing Plant

April 25, 2024

The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.

Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

April 25, 2024

The latest news for pharma industry insiders.

FDA Issues Complete Response Letter to Abeona Therapeutics Regarding PZ-Cel for Recessive Dystrophic Epidermolysis Bullosa

April 24, 2024

Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.